Outils & Documentation

Nos publications

Depuis sa création, l’Institut Roche a mis son expertise au profit de nombreuses publications scientifiques.

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. The European respiratory journal, 39(1), 172–179.

Borget, I., Cadranel, J., Pignon, J. P., Quoix, E., Coudert, B., Westeel, V., Dansin, E., Madelaine, J., Madroszyk, A., Friard, S., Daniel, C., Morin, F., Chouaid, C., & ERMETIC Collaborative Group (2012).

https://doi.org/10.1183/09031936.00201210
Voir plus

ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 22(3), 575–581.

Besse, B., Massard, C., Haddad, V., Andre, F., Dunant, A., Pirker, R., Olaussen, K. A., Brambilla, E., Fouret, P., & Soria, J. C. (2011).

https://doi.org/10.1093/annonc/mdq407
Voir plus
Plus de résultats :

Résultats :110/110